Chembio Diagnostics and LumiraDx Enter Collaboration to Develop New Point-of-Care Diagnostic Tests for Infectious Diseases

NEXT STORY
Ascendis Pharma A/S Announces Upcoming Investor Presentations
PREV STORY
Report from the Annual General Meeting of Immunicum AB (publ) on April 25, 2018
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

ChemoCentryx Reports Third Quarter 2018 Financial Results and Recent Highlights

-- Large, controlled clinical trial of avacopan in Hidradenitis Suppurativa (HS) on track to ...

author_avatar
NASDAQ Market News

MediWound Expands Latin American Distribution of NexoBrid Through Agreement With Avalon Pharmaceutical S.A

YAVNE, Israel, Jan. 21, 2016 (GLOBE NEWSWIRE) -- MediWound Ltd. (Nasdaq:MDWD), a fully-integrated biopharmaceutical ...

author_avatar
NASDAQ Market News

Corbus Pharmaceuticals Reports 2018 Second Quarter Financial Results and Provides Business Update

Lenabasum has reached Phase 3 clinical stage in two orphan autoimmune indications: systemic sclerosis ...

author_avatar
NASDAQ Market News